Dr Stéphane Rinfret is an academic interventional cardiologist and world-renowned expert in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). He completed a general and interventional cardiology fellowship at University of Montreal in 1999. He pursued a postgraduate fellowship at the Beth Israel Deaconess Medical Center and Harvard Clinical Research Institute (Harvard University), which he completed in 2001. He also obtained a Science Master’s (S.M.) degree in clinical epidemiology at the Harvard School of Public Health in 2001. Dr Rinfret spent the first 7 years of his career at the University of Montreal and moved in 2008 to the Laval University-Quebec Heart and Lung Institute where he spent 7 years and performed the first retrograde CTO PCI in Canada. He moved back to Montreal in 2016 to become the Director of Interventional Cardiology at the McGill University Health Centre where he built a high-volume CTO and Complex Higher risk but Indicated Procedures (CHIP) program. He moved to the United States in 2021 after being recruited at Emory Heart and Vascular and was appointed professor of Medicine at Emory University. He has published over 160 peer-reviewed articles and has been invited over 300 times to give lectures in the past 10 years. He is a high-volume coronary operator, with procedures performed predominantly in high-risk patients turned down for Coronary Artery Bypass Grafting (CABG) or with a complex post CABG coronary anatomy. He is the founder and co-director of the Multi-Level CTO course, the largest CTO-dedicated course in Europe. Dr Rinfret serves as faculty in many important cardiology meetings, and pursues very active clinical, research, proctoring and teaching career.
